These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37764941)

  • 1. Prolongation of Acid-Fast Bacilli Sputum Smear Positivity in Patients with Multidrug-Resistant Pulmonary Tuberculosis.
    Mvo S; Bokop C; Longo-Mbenza B; Vasaikar SD; Apalata T
    Pathogens; 2023 Sep; 12(9):. PubMed ID: 37764941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia.
    Sinshaw W; Kebede A; Bitew A; Tesfaye E; Tadesse M; Mehamed Z; Yenew B; Amare M; Dagne B; Diriba G; Alemu A; Getahun M; Fikadu D; Desta K; Tola HH
    BMC Infect Dis; 2019 Jul; 19(1):641. PubMed ID: 31324227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
    Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and CT characteristics of Xpert MTB/RIF-negative pulmonary tuberculosis.
    Lee HN; Kim JI; Kim YH
    PLoS One; 2021; 16(5):e0250616. PubMed ID: 33939723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Xpert MTB/RIF Assay, MTB Culture and Line Probe Assay for the Detection of MDR Tuberculosis in AFB Smear Negative Specimens.
    Lama C; Adhikari S; Sapkota S; Regmi RS; Ghimire GR; Banjara MR; Ghimire P; Rijal KR
    Diseases; 2022 Oct; 10(4):. PubMed ID: 36278581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
    Steingart KR; Sohn H; Schiller I; Kloda LA; Boehme CC; Pai M; Dendukuri N
    Cochrane Database Syst Rev; 2013 Jan; (1):CD009593. PubMed ID: 23440842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xpert MTB/RIF Use Is Associated With Earlier Treatment Initiation and Culture Conversion Among Patients With Sputum Smear-Negative Multidrug-Resistant Tuberculosis.
    Kipiani M; Graciaa DS; Buziashvili M; Darchia L; Avaliani Z; Tabagari N; Mirtskhulava V; Kempker RR
    Open Forum Infect Dis; 2021 Dec; 8(12):ofab551. PubMed ID: 34877367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study.
    Namugenyi J; Musaazi J; Katamba A; Kalyango J; Sendaula E; Kambugu A; Fehr J; Castelnouvo B; Manabe YC; Ssengooba W; Sekaggya-Wiltshire C
    BMC Infect Dis; 2021 Jun; 21(1):513. PubMed ID: 34074248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome correlation of smear-positivity for acid-fast bacilli at the fifth month of treatment in non-multidrug-resistant TB.
    Chien JY; Chen YT; Shu CC; Lee JJ; Wang JY; Yu CJ; Yang PC
    Chest; 2013 Jun; 143(6):1725-1732. PubMed ID: 23288018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid detection of extensively drug-resistant (XDR-TB) strains from multidrug-resistant tuberculosis (MDR-TB) cases isolated from smear-negative pulmonary samples in an Intermediate Reference Laboratory in India.
    Vashistha H; Hanif M; Saini S; Khanna A; Sharma S; Sidiq Z; Ahmed V; Dubey M; Chopra KK; Shrivastava D
    Indian J Tuberc; 2016 Jul; 63(3):144-148. PubMed ID: 27865234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-benefit analysis of Xpert MTB/RIF for tuberculosis suspects in German hospitals.
    Diel R; Nienhaus A; Hillemann D; Richter E
    Eur Respir J; 2016 Feb; 47(2):575-87. PubMed ID: 26647440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
    Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
    PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of Xpert MTB/RIF and sputum microscopy compared to sputum culture for diagnosis of tuberculosis in seven hospitals in Indonesia.
    Karuniawati A; Burhan E; Koendhori EB; Sari D; Haryanto B; Nuryastuti T; Gayatri AAAY; Bahrun U; Kusumawati RL; Sugiyono RI; Susanto NH; Diana A; Kosasih H; Naysilla AM; Lokida D; Neal A; Siddiqui S; Lau CY; Karyana M
    Front Med (Lausanne); 2022; 9():909198. PubMed ID: 36743681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the Xpert(®) MTB/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynaecology inpatient wards at the University Teaching Hospital, Lusaka, Zambia.
    Bates M; Ahmed Y; Chilukutu L; Tembo J; Cheelo B; Sinyangwe S; Kapata N; Maeurer M; O'Grady J; Mwaba P; Zumla A
    Trop Med Int Health; 2013 Sep; 18(9):1134-1140. PubMed ID: 23834035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial.
    Agizew T; Chihota V; Nyirenda S; Tedla Z; Auld AF; Mathebula U; Mathoma A; Boyd R; Date A; Pals SL; Lekone P; Finlay A
    BMC Infect Dis; 2019 Dec; 19(1):1058. PubMed ID: 31842773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture.
    Balcha TT; Sturegård E; Winqvist N; Skogmar S; Reepalu A; Jemal ZH; Tibesso G; Schön T; Björkman P
    PLoS One; 2014; 9(1):e85478. PubMed ID: 24465572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of time to sputum smear conversion in patients with pulmonary tuberculosis under treatment.
    Bisognin F; Amodio F; Lombardi G; Bacchi Reggiani ML; Vanino E; Attard L; Tadolini M; Re MC; Dal Monte P
    New Microbiol; 2019 Jul; 42(3):171-175. PubMed ID: 31157399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smear positive pulmonary tuberculosis and associated factors among homeless individuals in Dessie and Debre Birhan towns, Northeast Ethiopia.
    Semunigus T; Tessema B; Eshetie S; Moges F
    Ann Clin Microbiol Antimicrob; 2016 Aug; 15(1):50. PubMed ID: 27581729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.